BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 9049193)

  • 1. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S; Gow PJ; Vaughan RB; Angus PW
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Itha S; Sharma A; Bhatt G
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An analysis of hospital bacterial infections in cirrhotic patients undergoing selective intestinal decontamination].
    Tomás A; Soriano G; Guarner C; Teixidó M; Méndez C; Tena F; Fábrega E; Villanueva C; Such J; Balanzó J
    Rev Esp Enferm Dig; 1991 Apr; 79(4):259-64. PubMed ID: 2054213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
    Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
    Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
    Sandhu BS; Gupta R; Sharma J; Singh J; Murthy NS; Sarin SK
    J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
    Das A
    Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective intestinal decontamination prevents spontaneous bacterial peritonitis.
    Soriano G; Guarner C; Teixidó M; Such J; Barrios J; Enríquez J; Vilardell F
    Gastroenterology; 1991 Feb; 100(2):477-81. PubMed ID: 1985045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
    Corradi F; Brusasco C; Fernández J; Vila J; Ramirez MJ; Seva-Pereira T; Fernández-Varo G; Mosbah IB; Acevedo J; Silva A; Rocco PR; Pelosi P; Gines P; Navasa M
    Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.
    Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA
    Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.
    Francés R; Zapater P; González-Navajas JM; Muñoz C; Caño R; Moreu R; Pascual S; Bellot P; Pérez-Mateo M; Such J
    Hepatology; 2008 Mar; 47(3):978-85. PubMed ID: 18306221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
    Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
    J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial?
    Cholongitas E; Papatheodoridis GV; Manesis EK; Burroughs AK; Archimandritis AJ
    J Gastroenterol Hepatol; 2006 Mar; 21(3):581-7. PubMed ID: 16638103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of associated infections in community-acquired spontaneous bacterial peritonitis.
    Ho H; Zuckerman MJ; Ho TK; Guerra LG; Verghese A; Casner PR
    Am J Gastroenterol; 1996 Apr; 91(4):735-42. PubMed ID: 8677940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.